Variant report

Variant	esv32927
Chromosome Location	chr11:63377277-63387923
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:390)
CpG islands
(count:793)
Chromatin interactive
region (count:6)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:390 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr11:63381754-63382060	K562	blood:	n/a	n/a
2	ATF3	chr11:63380962-63381280	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr11:63384594-63384691	K562	blood:	n/a	n/a
4	BACH1	chr11:63381093-63381096	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr11:63378383-63378551	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr11:63381577-63382005	K562	blood:	n/a	chr11:63381715-63381731
7	BRCA1	chr11:63381655-63382033	Hela-S3	cervix:	n/a	n/a
8	CCNT2	chr11:63381251-63382133	K562	blood:	n/a	chr11:63381817-63381837
9	CEBPB	chr11:63381834-63382073	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr11:63383468-63383828	K562	blood:	n/a	chr11:63383640-63383651
11	CEBPB	chr11:63383602-63383797	H1-hESC	embryonic stem cell:	n/a	chr11:63383640-63383651
12	CEBPB	chr11:63378352-63378775	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr11:63383547-63383792	Hela-S3	cervix:	n/a	chr11:63383640-63383651
14	CEBPB	chr11:63383471-63383808	IMR90	lung:	n/a	chr11:63383640-63383651
15	CEBPB	chr11:63383488-63383791	A549	lung:	n/a	chr11:63383640-63383651
16	CEBPB	chr11:63378592-63378721	K562	blood:	n/a	n/a
17	CEBPB	chr11:63383462-63383770	HepG2	liver:	n/a	chr11:63383640-63383651
18	CHD2	chr11:63381649-63381804	K562	blood:	n/a	n/a
19	CHD2	chr11:63381649-63382118	Hela-S3	cervix:	n/a	chr11:63381807-63381817 chr11:63381947-63381957
20	CREB1	chr11:63381763-63382005	A549	lung:	n/a	n/a
21	CREB1	chr11:63381322-63382275	A549	lung:	n/a	n/a
22	CREB1	chr11:63381650-63382173	H1-hESC	embryonic stem cell:	n/a	n/a
23	CREB1	chr11:63380906-63381093	A549	lung:	n/a	n/a
24	CTBP2	chr11:63381019-63382072	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr11:63378660-63378810	AG04449	skin:	n/a	n/a
26	CTCF	chr11:63381257-63381332	MCF-7	breast:	n/a	n/a
27	CTCF	chr11:63379119-63379136	Lung_OC	lung:	n/a	n/a
28	CTCF	chr11:63381234-63381279	GM19240	blood:	n/a	n/a
29	CTCF	chr11:63378653-63378719	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTCF	chr11:63377560-63377710	HCPEpiC	choroid plexus:	n/a	n/a
31	CTCF	chr11:63380980-63381130	AG09319	gingival:	n/a	n/a
32	CTCF	chr11:63381140-63381290	GM12871	blood:	n/a	chr11:63381224-63381237
33	CTCF	chr11:63378620-63378770	HEK293	kidney:	n/a	n/a
34	CTCF	chr11:63380960-63381110	AG04449	skin:	n/a	n/a
35	CTCF	chr11:63380960-63381110	HEK293	kidney:	n/a	n/a
36	CTCF	chr11:63378600-63378750	AoAF	blood vessel:	n/a	n/a
37	CTCF	chr11:63381360-63381510	HRE	kidney:	n/a	n/a
38	CTCF	chr11:63381298-63381311	GM13977	blood:	n/a	n/a
39	CTCF	chr11:63381178-63381318	GM19238	blood:	n/a	chr11:63381224-63381237
40	CTCF	chr11:63378700-63378850	BJ	skin:	n/a	n/a
41	CTCF	chr11:63380940-63381090	HRE	kidney:	n/a	n/a
42	CTCF	chr11:63378360-63378510	HCPEpiC	choroid plexus:	n/a	chr11:63378444-63378457 chr11:63378434-63378447
43	CTCF	chr11:63378660-63378810	HUVEC	blood vessel:	n/a	n/a
44	CTCF	chr11:63380980-63381130	GM12872	blood:	n/a	n/a
45	CTCF	chr11:63379140-63379145	Lung_OC	lung:	n/a	n/a
46	CTCF	chr11:63382020-63382170	GM12868	blood:	n/a	n/a
47	CTCF	chr11:63381020-63381170	NHDF-neo	bronchial:	n/a	n/a
48	CTCF	chr11:63381860-63382010	GM12866	blood:	n/a	n/a
49	CTCF	chr11:63378620-63378770	HPAF	blood vessel:	n/a	n/a
50	CTCF	chr11:63378400-63378550	GM12866	blood:	n/a	chr11:63378444-63378457 chr11:63378434-63378447

(count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:63382085-63382135	NT2-D1	testis:	n/a
2	chr11:63383359-63383409	HEEpiC	esophagus:	n/a
3	chr11:63381728-63381778	AG04449	skin:	fetal
4	chr11:63381728-63381778	NHBE	bronchial:	n/a
5	chr11:63382065-63382115	RPTEC	kidney:	n/a
6	chr11:63385979-63386029	GM19239	blood:	n/a
7	chr11:63381845-63381895	SK-N-MC	brain:	n/a
8	chr11:63381144-63381194	HNPCEpiC	eye:	n/a
9	chr11:63381825-63381875	HCT-116	colon:	n/a
10	chr11:63385979-63386029	SK-N-MC	brain:	n/a
11	chr11:63378005-63378055	GM12891	blood:	n/a
12	chr11:63378005-63378055	HRE	kidney:	n/a
13	chr11:63381845-63381895	PANC-1	pancreas:	n/a
14	chr11:63383359-63383409	HIPEpiC	eye:	n/a
15	chr11:63381728-63381778	T-47D	breast:	n/a
16	chr11:63381728-63381778	HMEC	breast:	n/a
17	chr11:63381728-63381778	SAEC	small airway:	n/a
18	chr11:63385979-63386029	AG04449	skin:	fetal
19	chr11:63382065-63382115	HCF	heart:	n/a
20	chr11:63385979-63386029	HCM	heart:	n/a
21	chr11:63382085-63382135	AG09309	skin:	n/a
22	chr11:63381845-63381895	NHBE	bronchial:	n/a
23	chr11:63378005-63378055	NHBE	bronchial:	n/a
24	chr11:63382047-63382097	SAEC	small airway:	n/a
25	chr11:63382047-63382097	SK-N-SH_RA	brain:	n/a
26	chr11:63382095-63382145	NB4	blood:	n/a
27	chr11:63383359-63383409	HCF	heart:	n/a
28	chr11:63378005-63378055	HPAEpiC	pulmonary alveolar:	n/a
29	chr11:63382095-63382145	AG04450	lung:	fetal
30	chr11:63382065-63382115	HEEpiC	esophagus:	n/a
31	chr11:63382085-63382135	HNPCEpiC	eye:	n/a
32	chr11:63381845-63381895	HUVEC	blood vessel:	n/a
33	chr11:63382065-63382115	HUVEC	blood vessel:	n/a
34	chr11:63381825-63381875	NHBE	bronchial:	n/a
35	chr11:63381144-63381194	Hepatocyte	liver:	n/a
36	chr11:63381825-63381875	MCF-7	breast:	n/a
37	chr11:63383359-63383409	BJ	skin:	n/a
38	chr11:63381728-63381778	GM19239	blood:	n/a
39	chr11:63382095-63382145	IMR90	lung:	fetal
40	chr11:63385979-63386029	HRPEpiC	eye:	n/a
41	chr11:63381144-63381194	HMEC	breast:	n/a
42	chr11:63382067-63382117	HAEpiC	amniotic membrane:	n/a
43	chr11:63382095-63382145	BJ	skin:	n/a
44	chr11:63381825-63381875	NHDF-neo	bronchial:	n/a
45	chr11:63381144-63381194	AoSMC	blood vessel:	n/a
46	chr11:63378005-63378055	PrEC	prostate:	n/a
47	chr11:63381728-63381778	RPTEC	kidney:	n/a
48	chr11:63378005-63378055	H1-hESC	embryonic stem cell:	embryo
49	chr11:63381077-63381127	NT2-D1	testis:	n/a
50	chr11:63381077-63381127	HUVEC	blood vessel:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:63381325..63382017-chr2:85788347..85788975,2	Hela-S3	cervix:
2	chr11:63374913..63376548-chr11:63380673..63383197,2	K562	blood:
3	chr11:63369471..63371233-chr11:63378331..63380556,2	MCF-7	breast:
4	chr11:63376691..63378525-chr11:63379953..63383001,3	K562	blood:
5	chr11:63380134..63381907-chr11:63387073..63388722,2	K562	blood:
6	chr11:63381388..63381916-chr6:26158068..26158889,2	Hela-S3	cervix:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RTN3-2	chr11:63383780-63383884	ENSG00000203520.3

No data

Variant related genes	Relation type
ENSG00000203520	TF binding region
PLA2G16	TF binding region
ENSG00000203520	CpG island
PLA2G16	CpG island
ENSG00000118640	chromatin interactions
ENSG00000158373	chromatin interactions
ENSG00000176485	chromatin interactions
ENSG00000115486	chromatin interactions

Extended variants
information (count: 459 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:459 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2003932	chr11:63377319-63377320	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs12577770	chr11:63377327-63377328	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs34230138	chr11:63377381-63377382	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs562134370	chr11:63377406-63377407	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs183795571	chr11:63377458-63377459	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs544439152	chr11:63377473-63377474	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs564690218	chr11:63377517-63377518	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs533404283	chr11:63377528-63377529	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs12289689	chr11:63377534-63377535	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs12294233	chr11:63377543-63377544	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs528831939	chr11:63377553-63377554	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs141137494	chr11:63377558-63377559	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs11607689	chr11:63377621-63377622	Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs549423402	chr11:63377725-63377726	Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs17158439	chr11:63377828-63377829	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs537939902	chr11:63377870-63377871	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs188018044	chr11:63377891-63377892	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs116298613	chr11:63377908-63377909	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs115340157	chr11:63377969-63377970	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs554074945	chr11:63378008-63378009	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs374905099	chr11:63378036-63378037	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs574004337	chr11:63378043-63378044	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs573367418	chr11:63378074-63378075	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs562934870	chr11:63378081-63378082	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs542197490	chr11:63378092-63378093	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs35273464	chr11:63378099-63378100	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs191257731	chr11:63378112-63378113	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs575590222	chr11:63378120-63378121	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs59269807	chr11:63378167-63378168	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs564449391	chr11:63378215-63378216	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs145273867	chr11:63378218-63378219	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs78805749	chr11:63378291-63378292	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs560369667	chr11:63378319-63378320	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs147198927	chr11:63378334-63378335	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs140470198	chr11:63378368-63378369	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs574997466	chr11:63378431-63378432	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs376999533	chr11:63378435-63378436	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs531238718	chr11:63378453-63378454	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs551443886	chr11:63378519-63378520	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs571272033	chr11:63378551-63378552	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs557714737	chr11:63378592-63378593	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs34575823	chr11:63378619-63378620	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs112143885	chr11:63378660-63378661	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs7131579	chr11:63378671-63378672	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs376226556	chr11:63378704-63378705	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs556980328	chr11:63378715-63378716	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs536539079	chr11:63378859-63378860	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs115157845	chr11:63378894-63378895	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs575572845	chr11:63378915-63378916	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs537885834	chr11:63378922-63378923	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16272173	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Metanephric adenoma	20802469	CNVD
Chordoma	21602918	CNVD
Melanoma	18172304	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21785460	CNVD
Breast cancer	20409316	CNVD
Spinal muscular atrophy	17160897	CNVD
Retinitis pigmentosa	17160897	CNVD
Breast cancer	16417655	CNVD
Myelofibrosis	22110671	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	17217626	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	21045282	CNVD
Breast cancer	21806811	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Anaplastic thyroid cancer	18753363	CNVD
Breast cancer	22522925	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:613 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:63356800-63381000	Weak transcription	Sigmoid Colon	Sigmoid Colon
2	chr11:63357600-63380400	Weak transcription	NHLF	lung
3	chr11:63362000-63378000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
4	chr11:63367800-63377600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr11:63371000-63380400	Weak transcription	Aorta	Aorta
6	chr11:63374000-63378200	Enhancers	Placenta	Placenta
7	chr11:63374600-63380200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr11:63374800-63378400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
9	chr11:63374800-63380400	Weak transcription	K562	blood
10	chr11:63375000-63378600	Enhancers	NH-A	brain
11	chr11:63375600-63377600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr11:63375600-63378400	Enhancers	HMEC	breast
13	chr11:63375600-63378400	Enhancers	HSMM	muscle
14	chr11:63375800-63377600	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr11:63375800-63377600	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr11:63375800-63377600	Enhancers	iPS-15b Cell Line	embryonic stem cell
17	chr11:63375800-63377600	Enhancers	HSMMtube	muscle
18	chr11:63375800-63378000	Enhancers	HUES64 Cell Line	embryonic stem cell
19	chr11:63375800-63378200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
20	chr11:63375800-63378200	Enhancers	Duodenum Mucosa	Duodenum
21	chr11:63375800-63378400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr11:63375800-63378800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr11:63375800-63380200	Enhancers	Cortex derived primary cultured neurospheres	brain
24	chr11:63375800-63380400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr11:63376200-63378000	Enhancers	Placenta Amnion	Placenta Amnion
26	chr11:63376200-63378000	Enhancers	HUVEC	blood vessel
27	chr11:63376200-63378400	Enhancers	HUES48 Cell Line	embryonic stem cell
28	chr11:63376200-63378600	Enhancers	Small Intestine	intestine
29	chr11:63376200-63378600	Enhancers	Stomach Mucosa	stomach
30	chr11:63376200-63379200	Enhancers	H1 Cell Line	embryonic stem cell
31	chr11:63376400-63377400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
32	chr11:63376400-63377600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
33	chr11:63376400-63377800	Enhancers	Fetal Intestine Small	intestine
34	chr11:63376400-63378200	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
35	chr11:63376400-63378400	Enhancers	Right Ventricle	heart
36	chr11:63376400-63378600	Flanking Active TSS	Brain Substantia Nigra	brain
37	chr11:63376400-63379400	Flanking Active TSS	Brain Cingulate Gyrus	brain
38	chr11:63376600-63377400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
39	chr11:63376600-63377600	Enhancers	Fetal Intestine Large	intestine
40	chr11:63376600-63377800	Enhancers	Duodenum Smooth Muscle	Duodenum
41	chr11:63376600-63377800	Enhancers	Rectal Mucosa Donor 29	rectum
42	chr11:63376600-63377800	Enhancers	Osteobl	bone
43	chr11:63376600-63378000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
44	chr11:63376600-63378000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr11:63376600-63378000	Enhancers	Muscle Satellite Cultured Cells	--
46	chr11:63376600-63378200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
47	chr11:63376600-63378200	Enhancers	Lung	lung
48	chr11:63376600-63378200	Enhancers	Rectal Smooth Muscle	rectum
49	chr11:63376600-63378400	Flanking Active TSS	Brain Hippocampus Middle	brain
50	chr11:63376600-63378400	Enhancers	Colonic Mucosa	Colon

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links